Xihua Mao
Overview
Explore the profile of Xihua Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trott S, Lei F, Christian W, Mao X, Lehmkuhl B, Kejner A
Cancer Causes Control
. 2024 Jan;
35(5):817-824.
PMID: 38212533
Purpose: Populations with high cancer risk that are targeted for screening, education, and vaccination have been shown to increase rates of screening, which ultimately may improve timing of diagnosis and...
2.
Mao X, Omeogu C, Karanth S, Joshi A, Meernik C, Wilson L, et al.
BMC Cancer
. 2023 Jul;
23(1):644.
PMID: 37430191
Background: Associations between reproductive factors and breast cancer (BC) risk vary by molecular subtype (i.e., luminal A, luminal B, HER2, and triple negative/basal-like [TNBC]). In this systematic review and meta-analysis,...
3.
Cui Y, Zhan Z, Ma Y, Huang K, Liang C, Mao X, et al.
Respir Res
. 2022 Feb;
23(1):28.
PMID: 35151338
Background: Coronary artery disease (CAD) is a common comorbidity of chronic obstructive pulmonary disease (COPD). However, data related to the impact of CAD on outcomes of acute exacerbation of COPD...
4.
Zhan Z, Ma Y, Huang K, Liang C, Mao X, Zhang Y, et al.
Front Pharmacol
. 2022 Feb;
13:802123.
PMID: 35145412
Although medical guidelines discourage the use of methylxanthines in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), they are still widely used in clinical practice. This study investigated...
5.
Cui Y, Zhan Z, Zeng Z, Huang K, Liang C, Mao X, et al.
Front Med (Lausanne)
. 2021 Jun;
8:653777.
PMID: 34179040
Elevated eosinophils in chronic obstructive pulmonary disease (COPD) are recognized as a biomarker to guide inhaled corticosteroids use, but the value of blood eosinophils in hospitalized exacerbations of COPD remains...
6.
Ma Y, Huang K, Liang C, Mao X, Zhang Y, Zhan Z, et al.
Front Pharmacol
. 2021 Jun;
12:649884.
PMID: 34113250
The evidence for real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is insufficient. This study aimed to investigate real-world antibiotic use in the management of...
7.
Liang C, Mao X, Niu H, Huang K, Dong F, Chen Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Mar;
16:451-465.
PMID: 33658775
Purpose: The study aimed to give a comprehensive overview of characteristics and evaluate in-hospital clinical outcomes among hospitalized acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients in China using...
8.
Mao X, Liang C, Niu H, Dong F, Huang K, Chen Y, et al.
Respir Res
. 2021 Jan;
22(1):7.
PMID: 33407433
Background: Diabetes is a common comorbidity among patients with exacerbation of chronic obstructive pulmonary disease (AECOPD). Diabetes has been reported to be associated with length of stay (LOS), death, and...
9.
Karanth S, Fowler M, Mao X, Wilson L, Huang B, Pisu M, et al.
JNCI Cancer Spectr
. 2019 Dec;
3(4):pkz084.
PMID: 31840133
Background: Ovarian cancer remains a leading cause of death from gynecological malignancies. Race, socioeconomic status (SES), and access to health care are important predictors of quality treatment and survival. We...